Bristol Myers Squibb has signed Kasey Keller for a partnership around Breyanzi, giving the U.S. | Bristol Myers Squibb has ...
Since the industrial revolution, there has been a collective Western consensus that technology would continue to propel our world forward, further strengthening our personal and professional lives.
The first cancer cell therapies were personalized treatments made by isolating and engineering a patient’s own T cells in the lab—a complex, cumbersome, and expensive process. A slew of companies are ...
Bristol Myers Squibb has agreed to settle a lawsuit with two employees who were fired for refusing to get COVID-19 vaccines. The employees, Jeremy Beer and John Lott, filed a lawsuit in December 2021 ...
Patients undergoing a bone marrow or stem cell transplant face the prospect of a dangerous and potentially fatal immune response. The FDA has approved Bristol Myers Squibb drug Orencia as a way to ...
Bristol Myers Squibb Co. (BMS) has terminated its $1.3 billion-plus deal for Agenus Inc.’s anti-TIGIT bispecific antibody AGEN-1777 as part of a promised belt-tightening. In May 2021, BMS paid Agenus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results